The proposed high 6BN potency in reversing opioid dependence, if mediated by MOR-μ* to MOR-μ conversion, could result from both high affinity and low required receptor occupancy over long times, without acutely blocking agonist antinociception. This evidence concerns the gene OPRM1 and substance dependence.